Literature DB >> 18478273

"I was never like that": Australian findings on the psychological and psychiatric sequelae of corticosteroids in haematology treatments.

Pam McGrath1, Mary Anne Patton, Sarah James.   

Abstract

GOALS OF WORK: Corticosteroid treatments have been well documented to cause severe emotional and even psychiatric disturbances. Despite that corticosteroid use is at the core of most treatment protocols for haematological malignancies, there is a dearth of published research (and controversy in the existing research) on the emotional and psychiatric sequelae of corticosteroid use for haematology patients and its connection with pre-existing mental history. This paper aims to address this hiatus and confusion by examining the emotional and psychiatric side effects of corticosteroids on haematology patients in Australia.
MATERIALS AND METHODS: The findings are from a pilot study that explored the prior mental health history and effects of corticosteroid use of ten haematology patients in Australia. Data was collected through an iterative, phenomenological, qualitative research methodology using open-ended interviews conducted at the time and location of the participant's choice. The interviews were audio-recorded and transcribed verbatim. The language texts were then entered into the QSR NUD*IST computer program and analysed thematically. MAIN
RESULTS: The significant finding from the study was that corticosteroids used in haematology treatments have the potential to affect anyone and are not related to an individual's prior mental health history. No participant presented evidence of psychiatric history or counseling and many reported emotional stability during previous times of difficulty. All participants reported emotional distress directly related to corticosteroid use. Participants reported difficulties during the period of withdrawal from corticosteroids and relief during periods free from the administration of corticosteroids.
CONCLUSIONS: The findings provide evidence that emotional disturbances associated with corticosteroid use in haematology are a direct result of the drugs used and not a symptom of the individual's prior emotional health. Recommendations are given which have important implications for the management, support and education of patients and their families in relation to the potential emotional side effects from steroid administration and withdrawal.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18478273     DOI: 10.1007/s00520-008-0464-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  27 in total

Review 1.  [Corticosteroid therapy].

Authors:  W H Reinhart
Journal:  Praxis (Bern 1994)       Date:  2005-02-16

2.  Psychopathological and neuropsychological effects of 8-days' corticosteroid treatment. A prospective study.

Authors:  D Naber; P Sand; B Heigl
Journal:  Psychoneuroendocrinology       Date:  1996-01       Impact factor: 4.905

Review 3.  [Psychotic disorder secondary to suprarenal insufficiency caused by exogenous corticoids. Review of literature and a case report].

Authors:  Martín Ruiz; Eugenia Dabi; Daniel Matusevich; Carlos Finkelsztein
Journal:  Vertex       Date:  2002-12

4.  Mood changes during prednisone bursts in outpatients with asthma.

Authors:  E Sherwood Brown; Trisha Suppes; David A Khan; Thomas J Carmody
Journal:  J Clin Psychopharmacol       Date:  2002-02       Impact factor: 3.153

5.  'Enough is enough': qualitative findings on the impact of dexamethasone during reinduction/consolidation for paediatric acute lymphoblastic leukaemia.

Authors:  Pam McGrath; Lydia Pitcher
Journal:  Support Care Cancer       Date:  2001-11-16       Impact factor: 3.603

Review 6.  Steroid psychosis: a review.

Authors:  François Sirois
Journal:  Gen Hosp Psychiatry       Date:  2003 Jan-Feb       Impact factor: 3.238

7.  Acute psychosis complicating induction therapy for acute lymphoblastic leukemia.

Authors:  J M Ducore; D A Waller; G Emslie; S J Bertolone
Journal:  J Pediatr       Date:  1983-09       Impact factor: 4.406

8.  Sertraline treatment of mood disorder associated with prednisone: a case report.

Authors:  H Beshay; A J Pumariega
Journal:  J Child Adolesc Psychopharmacol       Date:  1998       Impact factor: 2.576

9.  Steroid-induced delirium in a patient with asthma: report of one case.

Authors:  Youngil I Koh; Inseon S Choi; Il-Seon Shin; Seo-Na Hong; Yeo-Kyeoung Kim; Myoung-Ki Sim
Journal:  Korean J Intern Med       Date:  2002-06       Impact factor: 2.884

10.  Factors associated with psychosis among patients with severe acute respiratory syndrome: a case-control study.

Authors:  Dominic T S Lee; Y K Wing; Henry C M Leung; Joseph J Y Sung; Y K Ng; G C Yiu; Ronald Y L Chen; Helen F K Chiu
Journal:  Clin Infect Dis       Date:  2004-09-24       Impact factor: 9.079

View more
  3 in total

1.  And Tell Yourself, "This is not Me, it's the Drug": Coping with the Psychological Impact of Corticosteroid Treatments in Hematology - Further Results from a Pilot Study.

Authors:  Pam McGrath; Mary Anne Patton; Michael Leahy
Journal:  Patient       Date:  2009-03-01       Impact factor: 3.883

2.  Living with relapsed myeloma: Symptoms and self-care strategies.

Authors:  Orlaith Cormican; Maura Dowling
Journal:  J Clin Nurs       Date:  2018-03-15       Impact factor: 3.036

3.  Living kidney donor and recipient perspectives on their relationship: longitudinal semi-structured interviews.

Authors:  Angelique F Ralph; Phyllis Butow; Jonathan C Craig; Germaine Wong; Steve J Chadban; Grant Luxton; Talia Gutman; Camilla S Hanson; Angela Ju; Allison Tong
Journal:  BMJ Open       Date:  2019-04-04       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.